Search

everythinglearnresearchcommunity

for

Search:↓

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Skin problems can indicate different diseases inside the body.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

New tools and criteria have been developed to better assess and treat pediatric lupus.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

New peptide biomaterials based on RADA16-I hydrogel can improve wound healing and could be used for tissue engineering.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Certain topical drugs can regrow hair in mice.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

Fluid viscosity affects fracture design and proppant placement in hydraulic fracturing.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Adalimumab may cause severe hair loss in some patients.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.